Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2132
https://www.valueinhealthjournal.com/article/S1098-3015(14)04062-5/fulltext
Title :
Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04062-5&doi=10.1016/j.jval.2014.08.2132
First page :
A609
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1594